APA (7th ed.) Citation

C, E., B, A., S, M., F, G., & CM, M. (2025). Reply to Yuan Du, Dan Liu, and Zhihui Guan's Letter to the Editor re: Cameron Englman, Busola Adebusoye, Davide Maffei, et al. Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Study. Eur Urol 2025;88:167-75. European urology, 88(6), e118. https://doi.org/10.1016/j.eururo.2025.09.005

Chicago Style (17th ed.) Citation

C, Englman, Adebusoye B, Mallett S, Giganti F, and Moore CM. "Reply to Yuan Du, Dan Liu, and Zhihui Guan's Letter to the Editor Re: Cameron Englman, Busola Adebusoye, Davide Maffei, Et Al. Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Study. Eur Urol 2025;88:167-75." European Urology 88, no. 6 (2025): e118. https://doi.org/10.1016/j.eururo.2025.09.005.

MLA (9th ed.) Citation

C, Englman, et al. "Reply to Yuan Du, Dan Liu, and Zhihui Guan's Letter to the Editor Re: Cameron Englman, Busola Adebusoye, Davide Maffei, Et Al. Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort Study. Eur Urol 2025;88:167-75." European Urology, vol. 88, no. 6, 2025, p. e118, https://doi.org/10.1016/j.eururo.2025.09.005.